Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC27688527;8528;8529 chr2:178770490;178770489;178770488chr2:179635217;179635216;179635215
N2AB27688527;8528;8529 chr2:178770490;178770489;178770488chr2:179635217;179635216;179635215
N2A27688527;8528;8529 chr2:178770490;178770489;178770488chr2:179635217;179635216;179635215
N2B27228389;8390;8391 chr2:178770490;178770489;178770488chr2:179635217;179635216;179635215
Novex-127228389;8390;8391 chr2:178770490;178770489;178770488chr2:179635217;179635216;179635215
Novex-227228389;8390;8391 chr2:178770490;178770489;178770488chr2:179635217;179635216;179635215
Novex-327688527;8528;8529 chr2:178770490;178770489;178770488chr2:179635217;179635216;179635215

Information

  • RefSeq wild type amino acid: N
  • RefSeq wild type transcript codon: AAC
  • RefSeq wild type template codon: TTG
  • Domain: Ig-17
  • Domain position: 62
  • Structural Position: 143
  • Q(SASA): 0.675
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
N/I rs747393998 0.193 0.984 D 0.607 0.712 0.902507848322 gnomAD-2.1.1 7.97E-06 None None None None N None 0 0 None 0 0 None 0 None 0 1.77E-05 0
N/I rs747393998 0.193 0.984 D 0.607 0.712 0.902507848322 gnomAD-4.0.0 1.59051E-06 None None None None N None 0 0 None 0 0 None 0 0 2.85646E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
N/A 0.3067 likely_benign 0.3982 ambiguous -0.337 Destabilizing 0.919 D 0.462 neutral None None None None N
N/C 0.3702 ambiguous 0.5131 ambiguous 0.524 Stabilizing 0.999 D 0.645 neutral None None None None N
N/D 0.1152 likely_benign 0.1187 benign -0.438 Destabilizing 0.896 D 0.421 neutral D 0.535645774 None None N
N/E 0.3582 ambiguous 0.3973 ambiguous -0.452 Destabilizing 0.919 D 0.38 neutral None None None None N
N/F 0.6091 likely_pathogenic 0.7258 pathogenic -0.615 Destabilizing 0.988 D 0.603 neutral None None None None N
N/G 0.2976 likely_benign 0.3644 ambiguous -0.553 Destabilizing 0.919 D 0.379 neutral None None None None N
N/H 0.1085 likely_benign 0.1284 benign -0.674 Destabilizing 0.059 N 0.308 neutral D 0.541252459 None None N
N/I 0.4584 ambiguous 0.6039 pathogenic 0.156 Stabilizing 0.984 D 0.607 neutral D 0.667520784 None None N
N/K 0.2864 likely_benign 0.3111 benign 0.028 Stabilizing 0.103 N 0.315 neutral D 0.547915958 None None N
N/L 0.4224 ambiguous 0.54 ambiguous 0.156 Stabilizing 0.976 D 0.524 neutral None None None None N
N/M 0.4454 ambiguous 0.5546 ambiguous 0.785 Stabilizing 0.999 D 0.531 neutral None None None None N
N/P 0.8902 likely_pathogenic 0.9367 pathogenic 0.019 Stabilizing 0.996 D 0.532 neutral None None None None N
N/Q 0.3011 likely_benign 0.3464 ambiguous -0.505 Destabilizing 0.976 D 0.363 neutral None None None None N
N/R 0.3505 ambiguous 0.3961 ambiguous 0.126 Stabilizing 0.851 D 0.357 neutral None None None None N
N/S 0.128 likely_benign 0.1488 benign -0.194 Destabilizing 0.896 D 0.417 neutral D 0.547203503 None None N
N/T 0.2182 likely_benign 0.2919 benign -0.068 Destabilizing 0.946 D 0.369 neutral D 0.605896078 None None N
N/V 0.4484 ambiguous 0.5846 pathogenic 0.019 Stabilizing 0.988 D 0.597 neutral None None None None N
N/W 0.8052 likely_pathogenic 0.8639 pathogenic -0.565 Destabilizing 0.999 D 0.65 neutral None None None None N
N/Y 0.1698 likely_benign 0.2201 benign -0.301 Destabilizing 0.968 D 0.531 neutral D 0.667608389 None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.